MedTrace Logo

Psoriasis Comorbidities at Hospital Calderón Guardia

NCT07448337 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2026-04-08

No results posted yet for this study

Summary

The goal of this observational study is to characterize the epidemiologic, clinical, severity, and therapeutic features of patients with psoriasis treated in Costa Rica between 2024 and 2025. The main questions it aims to answer are:

What are the demographic and clinical characteristics and severity profiles of psoriasis patients?

What treatments are used in routine clinical practice, and how are they associated with disease severity and outcomes?

Patients with psoriasis receiving dermatologic care during the study period will be included. Data will be obtained retrospectively from electronic medical records and clinical registries without intervention or modification of treatment.

Conditions

  • Psoriasis
  • Psoriasis Arthritis
  • Psoriasis (PsO)
  • Psoriasis Patients

Sponsors & Collaborators

  • Caja Costarricense de Seguro Social

    lead OTHER_GOV

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2027-05-31
Completion
2027-05-31

Countries

  • Costa Rica

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07448337 on ClinicalTrials.gov